loadpatents
name:-0.014358043670654
name:-0.0058238506317139
name:-0.0027050971984863
KIM; Uh-Hyun Patent Filings

KIM; Uh-Hyun

Patent Applications and Registrations

Patent applications and USPTO patent grants for KIM; Uh-Hyun.The latest application filed is for "novel adp-ribosyl cyclase and inhibitor thereof".

Company Profile
2.6.12
  • KIM; Uh-Hyun - Jeollabuk-do KR
  • Kim; Uh Hyun - Jeonju-si KR
  • Kim; Uh-Hyun - Jeonbuk KR
  • Kim, Uh-Hyun - Chollabuk-do KR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Novel Adp-ribosyl Cyclase And Inhibitor Thereof
App 20220235343 - KIM; Uh-Hyun ;   et al.
2022-07-28
Use of cADPR or NAADP antagonists
Grant 11,071,748 - Kim , et al. July 27, 2
2021-07-27
USE OF cADPR OR NAADP ANTAGONISTS
App 20200046750 - Kim; Uh Hyun ;   et al.
2020-02-13
Composition For Controlling Secretion Of Prostasomes And Use Thereof
App 20190298745 - Park; Kwang Hyun ;   et al.
2019-10-03
Method of regulating fertilizing ability using cyclic ADP-ribose and CD38
Grant 9,180,171 - Kim , et al. November 10, 2
2015-11-10
Pharmaceutical or cosmetic composition containing nicotinic acid adenine dinucleotide phosphate or derivative thereof
Grant 8,816,065 - Kim , et al. August 26, 2
2014-08-26
Method Of Regulating Fertilizing Ability Using Cyclic Adp-ribose And Cd38
App 20130224177 - Kim; Uh-Hyun ;   et al.
2013-08-29
Pharmaceutical Or Cosmetic Composition Containing Nicotinic Acid Adenine Dinucleotide Phosphate Or Derivative Thereof
App 20130137177 - Kim; Kwang-Nyeon ;   et al.
2013-05-30
Composition For Preventing Or Treating Diabetes Comprising Nad Glycohydrolase Inhibitor As Active Ingredient
App 20130123142 - Kim; Uh-Hyun ;   et al.
2013-05-16
Stilbene derivatives for ADP-ribosyl cyclase inhibitors
Grant 8,314,082 - Kim , et al. November 20, 2
2012-11-20
Method Of Regulating Fertilizing Ability Using Cyclic Adp-ribose And Cd38
App 20120189607 - Kim; Uh-Hyun ;   et al.
2012-07-26
Use of nicotinic acid adenine dinucleotide phosphate or derivative thereof as agent for treating type-2 diabetes
Grant 8,133,872 - Kim , et al. March 13, 2
2012-03-13
Stilbene Derivatives For Adp-ribosyl Cyclase Inhibitors
App 20110281826 - Kim; Uh-Hyun ;   et al.
2011-11-17
Stilbene Derivatives For Adp-ribosyl Cyclase Inhibitors
App 20100069619 - Kim; Uh-Hyun ;   et al.
2010-03-18
Use Of Nicotinic Acid Adenine Dinucleotide Phosphate Or Derivative Thereof As Agent For Treating Type-2 Diabetes
App 20090306006 - Kim; Uh Hyun ;   et al.
2009-12-10
Use of L-2-oxothiazolidine-4-carboxylic acid for the treatment of type 2 diabetes
App 20020137779 - Kim, Uh-Hyun ;   et al.
2002-09-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed